The QualityStocks Daily Tuesday, March 12th, 2019

Today's Top 3 StockMarketWatch

StockMarketWatch (OPTT) +2,158.06%

Schaeffer's (SFIX) +25.20%

Penny Stock Titans (CDTAF) +20.34%

The QualityStocks Daily Stock List

Durango Resources, Inc. (ATOXF)

OTC Markets, MarketWatch, Barchart, Wallet Investor, High Rising Stocks, OTC Stock Watch, Resource World, Penny Stock Hub, Stockhouse, InvestorX, Investors Guru, Stockwatch, and Jet Life Penny Stocks reported earlier on Durango Resources, Inc. (ATOXF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Durango Resources, Inc. acquires and explores for precious and base mineral properties in Canada. The Company has a large asset pool of claims. It has projects in strategic areas adjoining Osisko, Nemaska Lithium, Lakeshore Gold, GT Gold, and Garibaldi Resources. Incorporated in 2006, Durango Resources has its corporate headquarters in Vancouver, British Columbia. The Company’s common shares commenced trading on the OTCQB® Venture Market in the U.S. under the symbol “ATOXF” on March 13, 2018.

Durango Resources has 100 percent owned Canadian properties. The Company’s properties include Dianna Lake, Saskatchewan; Whitney Northwest, Ontario; NMX East, Quebec; Decouverte (Discovery), Quebec; Mayner’s Fortune, British Columbia; Windfall Lake Properties, Quebec; and Buckshot Graphite, Quebec.

The Decouverte Property in James Bay, Quebec had an independent technical review completed as reported on January 16, 2018. The review supports a drilling program of 3,800 meters across 36 holes. Decouverte is a grassroots gold project. It is targeting greenstone-hosted orogenic gold mineralization. The Decouverte property is 57 square kilometers (5,700 ha). Six target areas are defined on the property. Each of these ranges from 100 meters to 400 meters along strike.

Durango Resources will continue to hold 100 percent interest in its Trove Property in Québec. The Trove Property is 1,188 hectares in size. It is among the Windfall Lake gold deposit - one of the highest-grade resource stage gold projects in Canada. The Trove claims are in the Windfall-Urban Gold Camp district of northern Québec surrounded by properties held by Osisko Mining, Inc. and are a direct extension of the southwest mineralized trend that BonTerra Resources, Inc. is exploring on its Gladiator Gold Deposit and Coliseum Gold property.

Durango Resources announced in 2018 that it entered into a property purchase agreement to acquire an additional 2,358 hectares in Windfall Lake, Québec. The Property is in a key position of the Urban-Barry Greenstone belt of Québec. It is positioned approximately 5.5km south of Osisko Mining’s Black Dog Project, and roughly 10km south of the Barry Gold Deposit, now owned by BonTerra Resources.

This past December, Durango Resources announced that an airborne survey conducted on its wholly-owned Trove property in the Windfall Lake Urban Barry region of Quebec outlined a magnetic anomaly. An airborne survey was completed by BonTerra Resources while the property was under option to BonTerra in 2018. The survey shows an anomaly following the regional fault that trends through the property.

Also, in December, Durango Resources reported that further to its news of November 2, 2018, the Company received further positive assay results on the additional till samples taken on the East claim block at Windfall Lake, Québec. Nine additional till samples were obtained down strike along the same gold trend where earlier gold grains were discovered on the East block of claims. Each of the samples submitted for gold grain count and fire assay have once again all returned visible gold grains extending the earlier known 5km trend to roughly 10km.

Durango Resources, Inc. (ATOXF), closed Tuesday's trading session at $0.055, even for the day, on 100,000 volume. The average volume for the last 3 months is 6,039 and the stock's 52-week low/high is $0.037/$0.0694.

chart

TechPrecision Corp. (TPCS)

BullRally, MadPennyStocks, Marketbeat, StreetInsider, Energy and Capital, Wealth Daily, TopPennyStockMovers, Zacks, Stock Market News Alert, HotOTC, CoolPennyStocks, PennyStockVille, Stock Rich, FeedBlitz, and SmallCapVoice reported earlier on TechPrecision Corp. (TPCS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

TechPrecision Corp., via its wholly-owned subsidiaries, Wuxi Critical Mechanical Components Co., Ltd., and Ranor, Inc., is an industry leading manufacturer of precision, large-scale fabricated and machined metal components and tested systems. The Company’s vision is to be an end-to-end global service provider to its customers through furnishing customized and integrated turn-key solutions for completed products requiring custom fabrication and machining, assembly, inspection, and testing. TechPrecision is headquartered in Westminster, Massachusetts. The Company lists on the OTC Markets Group’s OTCQB.

The Company has the fabrication capacity to see a client’s large-scale components through from initial processing to final finishing and assembly. This does away with the need for outside servicing. In addition, it helps ensure lower costs. TechPrecision’s products are used in the alternative energy, medical, nuclear, defense, and precision industrial, aerospace, and naval/maritime markets, among others.

TechPrecision’s Ranor subsidiary specializes in large-scale, precision component fabrication for the Clean Technology, Energy, Medical, Aerospace, and Defense sectors. Ranor’s capabilities include Production Control; Engineering; Processing; Fabrication; Machining; Assembly & Finishing; Quality Assurance, and NDE & Inspection.

Ranor has a proven history of prototype and full-scale production success. It delivers turnkey components for challenging applications. Ranor has experience producing an array of large-scale critical components to the tightest tolerances and specifications. As a result, this has given it insights that may be able to help optimize a customer’s designs for manufacturability.

The design of the Wuxi Critical Mechanical Components (CMC) subsidiary is to meet the growing global demand for an experienced, knowledgeable machining and distribution center in Asia, providing large-scale component fabrication solutions for the region’s wind power and solar challenges. CMC uses one of the largest forges in the industry.

CMC’s capabilities include Forging; Fabrication; Machining; Inspection; Assembly & Finishing, and Quality Assurance. CMC serves the Solar/LED; Wind; Nuclear; Clean Technology, Medical; as well as General Industrial industries.

TechPrecision Corp. (TPCS), closed Tuesday's trading session at $0.95, down 1.04%, on 66,803 volume with 52 trades. The average volume for the last 3 months is 32,861 and the stock's 52-week low/high is $0.47/$1.07.

chart

Mentor Capital, Inc. (MNTR)

Wealth Insider Alert, Stock Profile, Promotion Stock Secrets, Laissez Faire Today, BUYINS.NET, Stocks That Move, Market Intelligence Center Alert, Investors Underground, Cancer Roll Up Strategy, Stockgoodies, StreetAuthority Daily, and Five Star Stock Picks reported previously on Mentor Capital, Inc. (MNTR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mentor Capital, Inc. provides mezzanine financing to leaders in the cannabis arena. The Company looks to come alongside and assist larger private medical marijuana and cannabis companies and their founders in meeting their liquidity, and financial objectives, to add protection for investors, and to help incubate private cannabis companies. Mentor Capital is based in San Diego, California. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Mentor Capital participates in the legal recreational marijuana market. Nonetheless, the Company’s favored focus is medical. It looks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, lessening ocular pressures from glaucoma, in addition to decreasing chronic pain. Mentor takes a major position in the varied members of its portfolio of participating companies. However, it leaves operating control in the hands of the cannabis company founders.

The Company’s preferred involvement is with larger and private pre-IPO (Initial Public Offering) medical marijuana companies that it can help operationally prepare for the public market and finance, sometimes working with institutional partners looking for public liquidity. Mentor migrated to the cannabis space from front-line cancer investments.

In February of last year, Mentor Capital announced that it extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Mentor stated it would be pleased to make a series of cannabis focused investments with cannabis veteran and Pueblo Founder, Mr. Pat Leonard. Mentor Capital has set up Mentor Partner II, LLC as a channel for this purpose.

Mentor Capital’s belief is that there is considerable opportunity to approach the medical marijuana and adult use market as a business-focused, high-integrity, public company providing substantially more financing to private cannabis companies. Originally, the Company was established in Silicon Valley in 1985 with $1,000 by current Chief Executive Officer, Mr. Chet Billingsley. Mentor completed dozens of early private acquisitions and the Company went public in 1996.

Mentor Capital, Inc. (MNTR), closed Tuesday's trading session at $0.461, down 7.10%, on 40,201 volume with 45 trades. The average volume for the last 3 months is 85,461 and the stock's 52-week low/high is $0.30/$1.48.

chart

American Rebel Holdings, Inc. (AREB)

Wallet Investor, Market Screener, OTC Markets, Stockwatch, Trading View, Dividend Investor, Penny Stock Hub, Capital Cube, Investors Hangout, Stocks News Feed, Street Insider, Simply Wall St, Morningstar, 4-Traders, Barchart, Wallmine, and MarketWatch reported previously on American Rebel Holdings, Inc. (AREB), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

American Rebel Holdings, Inc. is positioning itself as America's Patriotic Brand. It engages in developing diverse products in the self-defense and patriotic product areas. The Company centers on designing, manufacturing, and marketing concealed carry backpacks under the American Rebel brand name. Mr. Charles A. "Andy" Ross founded the Company as America's Patriotic Brand. American Rebel Holdings has its corporate headquarters in Nashville, Tennessee. The Company lists on the OTC Markets’ OTCQB.

American Rebel’s first product offering is its line of concealed carry products. These were launched at the 2017 NRA (National Rifle Association) Annual Meeting. The design of the Company’s products is to give one the tools needed to defend and protect oneself, their family and more. The Cartwright Concealed Carry Coat by American Rebel is featured in the third installment of a five-part series in the NRA Publication America's 1st Freedom on how to choose the proper handgun to carry for defensive purposes.

This year, American Rebel Holdings is expanding its product offerings to include Large Floor Gun Safes, Wall Safes, as well as Personal Safes. Mr. Andy Ross, American Rebel Chief Executive Officer (CEO), said, "American Rebel products keep you concealed and safe inside and outside the home."

American Rebel Safes will protect one’s firearms and valuables from theft, fire, natural disasters and in a place only appropriate members of the household can access. Mr. Nathan Findley, who comes to American Rebel Holdings with more than 10 years' experience in the outdoor and firearms industries, will lead American Rebel's expansion in gun safes.

Recently, American Rebel reported sales four times greater than 2018 at the NRA Great American Outdoor Show in Harrisburg, Pennsylvania from February 2-10, 2019. The Company said that the Cartwright Concealed Carry Coats and Cartwright Concealed Carry Backpacks were the top sellers during the trade show. These were followed by the Men's Freedom Jackets. American Rebel CEO Mr. Andy Ross appeared on a recent edition of MoneyTV to report the strong results.  

American Rebel Holdings, Inc. (AREB), closed Tuesday's trading session at $0.65, even for the day, on 10 volume with 1 trade. The average volume for the last 3 months is 1,732 and the stock's 52-week low/high is $0.15/$2.50.

chart

EnviroLeach Technologies, Inc. (EVLLF)

Stock Market Revolution, Investopedia, Marketwired, Stockhouse, GuruFocus, 4-Traders, Dividend Investor, OTC Markets, Barchart, Streetwise Reports, MarketWatch, and Investors Hub reported previously on EnviroLeach Technologies, Inc. (EVLLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

EnviroLeach Technologies, Inc. is a technology business and near-term gold producer. It engages in the development and commercialization of environmentally-friendly formulas and technologies for the treatment of materials in the mining and E-Waste sectors. Its goal is to become a top gold producer through the “Urban-Mining” of end-of-life electronics and to be a significant player in the extraction of precious metals in the traditional mining space. EnviroLeach Technologies is headquartered in Burnaby, British Columbia.

The EnviroLeach reagent is well suited for the leaching of gold in an agitated or vat leach type process. This includes the treatment of whole ores, gravity concentrates, flotation concentrates, and also E-Waste. This segment of the market represents most of the global gold produced.

Using its proprietary non-cyanide, non-acid based process, EnviroLeach extracts precious and base metals from ores, concentrates, and E-Waste using only Food and Drug Administration (FDA) approved additives. EnviroLeach developed a unique, cost-effective and environmentally-friendly alternative to cyanide and strong-acid based processes now used for the extraction of precious metals from mineral ores, concentrates, and E-Waste.

The process is alike to the standard cyanide vat leaching circuits used today. However, it is much safer and simpler. The patent-pending EnviroLeach formula consists of combining five non-toxic, FDA approved dry ingredients with ambient temperature water. In 2017, EnviroLeach Technologies and Mineworx Technologies successfully advanced their proven chemical formulas and mechanical processes with a number of additional proprietary and patent-pending breakthroughs.

The new discoveries include major enhancements to the proven EnviroLeach E-Waste process regarding improved leach kinetics, improved recoveries, metal complex stability, element selectivity, metal precipitation and the reusability of the main solution. The two companies also completed the design, engineering and construction of the initial production scale, 10 tonne per day E-Waste processing plant that was installed on-schedule and on-budget at the Memphis, Tennessee facility.

This week, EnviroLeach Technologies reported independent analytical results from SGS, a world leading inspection, verification, testing and certification company. The research work was commissioned by EnviroLeach Technologies as part of its enhanced third party, independent validation program.

The initial series of leach tests were conducted on high-grade samples. This includes gravity concentrate tails and flotation concentrates. Tests on oxidized material generated from autoclaving and roasting attained more than 94 percent within two hours. The results, using the EnviroLeach Technologies formulas, indicate that gold recoveries of greater than 85 percent were realized on the table tails within 24 hours and more than 90 percent recoveries from Flotation Concentrate within 24 hours.

Today, EnviroLeach Technologies announced that Company Management will present at the 31st Annual ROTH Conference on Monday, March 18, 2019, at 8:00AM Pacific Time at the Ritz Carlton Laguna Nigel in Dana Point, California.  Mr. Duane Nelson, Chief Executive Officer, will be participating on the panel of “Sustainability: How to Uncover Key Efforts & Initiatives which Drive Outperformance” on March 18 at 9:30-10:30AM. The EnviroLeach corporate presentation will be on Tuesday, March 19 at 2:30-3:00PM.

EnviroLeach Technologies, Inc. (EVLLF), closed Tuesday's trading session at $0.543, up 2.45%, on 26,330 volume with 17 trades. The average volume for the last 3 months is 33,408 and the stock's 52-week low/high is $0.50/$1.48.

chart

Maple Gold Mines Ltd. (MGMLF)

Jet Life Penny Stocks, Junior Mining Network, Dividend Investor, Wallet Investor, InvestorsHub, GuruFocus, Investors Hangout, Wall Street Nation, OTC Markets, Stockwatch, Stockhouse, 4-Traders, MarketWatch, TradingView, and Barchart reported beforehand on Maple Gold Mines Ltd. (MGMLF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Maple Gold Mines Ltd. is an exploration company focused on advancing a district-scale gold project in one of the world’s premier mining jurisdictions. The Company’s 377 km2 Douay Gold Project is within the prolific Abitibi Greenstone Belt in northern Quebec. OTCQB-listed, Maple Gold Mines has its management office in Toronto, Ontario. The Company formerly went by the name Aurvista Gold Corporation. It changed its name to Maple Gold Mines Ltd. in November 2017.

The Douay Gold Project has first-rate infrastructure with large operating mines within 150 kms. There is significant resource expansion and exploration upside at the Douay Gold Project. The Project has an established gold resource that remains open in numerous directions. Maple Gold is centering on expanding the known resource areas and testing new discovery targets within its 55 km of strike along the Casa Berardi Deformation Zone.

The updated resource estimate (NI 43-101 Technical Report - March 2018) successfully converted a significant proportion of Inferred to the Indicated Resource category, at Douay West and Porphyry Zones. Resources at Douay now stand at 2.76 million ounces Inferred plus 0.48 million ounces Indicated.

Last month, Maple Gold Mines announced it added $1.9M to its treasury after receiving its full 2017 tax credit refund from Revenu Québec. The winter 2019 drill program is testing refined higher-grade targets generated from recently reported 3D modeling work. Mapping and gold deportment work will continue through summer 2019.

A new resource update is expected in late Q1. In addition, Maple Gold plans to start a Preliminary Economic Assessment (PEA) in late 2019. It has designed a 10,000 meter program. The Company plans to drill a minimum of 5,000 meters this winter focused on different targets.

Mr. Matthew Hornor, Maple Gold's President and Chief Executive Officer, said: "We have ranked and prioritized all of our drill targets and with more than $4M in the treasury we are now in position to test top priority drill targets, while concurrently working with RPA on our new resource estimate for Douay."

Maple Gold Mines Ltd. (MGMLF), closed Tuesday's trading session at $0.07, even for the day, on 153,436 volume with 14 trades. The average volume for the last 3 months is 94,478 and the stock's 52-week low/high is $0.064/$0.229.

chart

Namaste Technologies, Inc. (NXTTF)

InvestorsHub, Profit Confidential, OTC Markets, MarketWatch, Insider Financial, MicroCapDaily, Marketwired, Seeking Alpha, Investors Hangout, Stockhouse, Trading View, Stockhouse, Barchart, Daily Marijuana Observer, and New Cannabis Ventures reported earlier on Namaste Technologies, Inc. (NXTTF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Namaste Technologies, Inc. is the largest online retailer for medical cannabis delivery systems internationally. The Company operates the largest global cannabis e-commerce platform with greater than 30 websites in 20-plus countries under different brands. Namaste’s long-term strategy is to become a top supplier of legal cannabis products as the cannabis market is legalized in each country. OTCQB-listed, Namaste Technologies is based in Toronto, Ontario.

Namaste has majority market share in Europe and Australia. The Company has operations in the United States, the United Kingdom, Canada and Germany. Furthermore, it has opened new supply channels into developing markets. These include Brazil, Mexico, and Chile.

Through vaporizer sales and the selling of glass and pipes and other dry herb related paraphilia, the Company has a very strong channel to sell to end consumers once it is legalized worldwide. Namaste Technologies owns and operates online retail sites with a presence in many nations. The Company is a global leader in delivery systems for dry herbs, which can include medicinal cannabis where legally available.

Namaste has developed and acquired innovative technology platforms. This includes NamasteMD.com, Canada's first Health Canada compliant telemedicine application. In May of 2018, Namaste acquired a top e-commerce artificial intelligence (AI) and Machine Learning Company, Findify AB. Findify uses AI algorithms to optimize and personalize a consumer's on-site buying experience.

Namaste Technologies has acquired Cannmart, Inc. This is a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program). Through Cannmart, Namaste is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Additionally, the Company is active in product development and manufacturing. Wholly-owned subsidiary Cannmart has received its Access to Cannabis for Medical Purposes Regulations (ACMPR) Production License.

This month, Namaste Technologies announced that it entered into a share purchase agreement to acquire 49 percent of the issued and outstanding shares of Calgary, Alberta based Choklat, Inc. for $1.5 million in cash consideration. As part of this acquisition, Namaste Technologies will be appointing a member to the Board of Directors of Choklat. Choklat is a premium chocolate manufacturer. It has existing sales through its online eCommerce site and via a network of distributors throughout Canada.

Meni Morim, Interim Chief Executive Officer of Namaste Technologies, said, "Choklat is a great acquisition for us with a vast offering of existing products that can be easily infused with THC or CBD and sold as edibles. Their small batch manufacturing model is a great fit within the new proposed regulations for edible cannabis products. This transaction provides the security of supply and manufacturing for our medicinal cannabis customers and provides capacity for the recreational market in the event proposed regulations are passed."

Namaste Technologies, Inc. (NXTTF), closed Tuesday's trading session at $0.5796, down 0.74%, on 820,744 volume with 503 trades. The average volume for the last 3 months is 1,107,678 and the stock's 52-week low/high is $0.45/$3.05.

chart

Acura Pharmaceuticals, Inc. (ACUR)

CRWEWallStreet, PennyToBuck, StreetInsider, Marketbeat, SmarTrend Newsletters, Wall Street Resources, PennyOmega, PennyStocks24, Penny Stock Rumble, The Street, BestOtc, BUYINS.NET, CRWEFinance, StockHotTips, and DrStockPick reported on Acura Pharmaceuticals, Inc. (ACUR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company innovating abuse deterrent drugs. It engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse, utilizing its proprietary LIMITx™, AVERSION®, and IMPEDE® Technologies. OTCQB-listed, Acura Pharmaceuticals is based in Palatine, Illinois.

The patented LIMITx technology works by neutralizing stomach acid with buffering ingredients as increasing numbers of tablets are swallowed. It relies on stomach acid to play a role in the release and subsequent systemic absorption of the active ingredient from micro-particles contained in the tablets.

The intention of the LIMITX™ Technology is to address an oral Excessive Tablet Abuse (ETA) or accidental consumption of multiple tablets and provide a margin of safety during accidental over-ingestion of tablets. Additionally, LIMITX™ is expected to exhibit barriers to abuse by snorting and injection. LTX-04 is Acura’s lead development candidate employing its novel LIMITx™ technology.

AVERSION® Technology is a patented composition of commonly used active and inactive pharmaceutical ingredients providing abuse deterrent features and benefits for orally administered pharmaceutical drug products. The intention of AVERSION® Technology opioid analgesic product candidates is to provide effective relief from pain. This is while discouraging common methods of pharmaceutical product misuse and abuse.

OXAYDO® (oxycodone HCl immediate-release tablets), which incorporate the AVERSION Technology, is Food and Drug Administration (FDA) approved and marketed in the United States by Acura’s partner Egalet Corp.

The IMPEDE® Technology platform is an advanced polymer matrix. It is used in NEXAFED®, Acura Pharmaceuticals’ pseudoephedrine (PSE) tablet product, to limit or disrupt the extraction of PSE from tablets for conversion into the illicit drug methamphetamine.

NEXAFED® and NEXAFED® Sinus are pseudoephedrine containing products that use the IMPEDE Technology. They are marketed in the United States by Acura Pharmaceuticals’ partner MainPointe Pharmaceuticals.

Recently, Acura Pharmaceuticals announced financial results for the three and six months ended June 30, 2018. Acura reported a Net Loss of $2.8 million or $0.13 per diluted share for the six months ended June 30, 2018, versus a Net Loss of $1.7 million or $0.15 per diluted share for the same period in 2017. For the Q2 2018, it reported a Net Loss of $1.3 million or $0.06 per diluted share versus a Net Loss of $2.2 million or $0.18 per diluted share for the same period in 2017.

Acura Pharmaceuticals, Inc. (ACUR), closed Tuesday's trading session at $0.205, even for the day, on 4,712 volume with 5 trades. The average volume for the last 3 months is 11,140 and the stock's 52-week low/high is $0.0601/$0.74.

chart

Bravada Gold Corp. (BGAVF)

Gold Investment Letter, Penny Stock Hub, 4-Traders, NorthernVertex, Stockhouse, Morningstar, Cambridge House International, The Street, Dividend Investor, The Prospector News, and Real Pennies reported on Bravada Gold Corp. (BGAVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Bravada Gold Corp. is a Nevada-focused exploration and development company. It has a large portfolio of high-quality properties. These properties include a range of development stages. This is from early-stage exploration to advanced-stage exploration and pre-development. Bravada Gold is based in Vancouver, British Columbia and the Company lists on the OTC Markets Group’s OTCQB.

Bravada Gold retains residual working or royalty interests. The Company explores for precious metals in well-established gold trends in one of the world’s best gold jurisdictions.

At present, five of Bravada’s Nevada properties are being backed by partners. In total this includes earn-in work expenditures of up to $6.5 million and payments to Bravada Gold of up to +$3.0 million in cash and shares. Bravada holds a royalty on eventual barite production on its Shoshone Pediment Project.

Regarding its Wind Mountain project, the Company’s plan is to drill-test for high-grade “Hishikari-type” gold/silver vein mineralization under the existing disseminated resource at Wind Mountain. Pertaining to the SF property, Bravada Gold plans to drill-test for high-grade “Carlin-type” gold mineralization at the property.

Concerning the North Lone Mountain and South Lone Mountain projects, plans have not been finalized for Bravada Gold’s two claim groups. However, Nevada Zinc continues to expand the footprint of zinc mineralization on its claims towards Bravada Gold’s South Lone Mountain claims. Should Nevada Zinc complete the purchase of these claims, Bravada will retain a royalty on base and precious metals.

Bravada Gold received earlier this year, subject to posting a reclamation bond, approval of its drilling permit from the U.S. Forest Service for its Quito Gold property. The permit allows four sites to be drilled at the Quito Extension target in 2018. Numerous holes can be drilled from these sites. The Quito Property is situated along the Austin Gold trend in central Nevada.

Bravada Gold, by way of its wholly-owned U.S. subsidiary Bravo Alaska, Inc.,  and Yamana Gold, Inc., through its wholly-owned U.S. subsidiary Meridian Minerals Corp. (collectively Yamana), have agreed to amend the earn-in agreement for the Quito Property.

This amendment will remove a "Claw-back" provision, which allowed Yamana Gold to re-acquire a 51 percent ownership in Quito after earn-in by Bravada Gold of a 70 percent working interest (WI) in the property with all other terms remaining constant. As consideration for the amendment, Yamana Gold receives 1,000,000 common shares in Bravada Gold and warrants to buy 1,000,000 common shares at CDN$0.15 for a period of three years.

Recently, Bravada Gold announced that the earlier announced $480,000 non-brokered private placement has been oversubscribed. The Company will now issue 6,584,000 units in a non-brokered private placement at a price of $0.08 per Unit for gross proceeds of $526,720. Net proceeds from the private placement will be used for property maintenance fees, permitting fees and associated ancillary costs, and accounts payable and for working capital.

Bravada Gold Corp. (BGAVF), closed Tuesday's trading session at $0.0524, up 12.69%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 32,726 and the stock's 52-week low/high is $0.039/$0.0875.

chart

ZIVO Bioscience, Inc. (ZIVO)

RedChip and Ceocast News reported earlier on ZIVO Bioscience, Inc. (ZIVO), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

ZIVO Bioscience, Inc.’s dedication is to the development and commercialization of nutritional compounds and bioactive molecules derived from its proprietary algal strains. Additionally, the Company engages in the development of natural bioactive compounds for use as dietary supplements and food ingredients, and biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically centered on autoimmune and inflammatory response modulation.

Listed on the OTC Markets’ OTCQB, ZIVO Bioscience is based in Keego Harbor, Michigan. The Company’s wholly-owned subsidiary is WellMetris, LLC.

ZIVO Bioscience is re-inventing itself as a licensor of internally developed intellectual property (IP), which includes its proprietary algae cultures, in addition to IP secured via strategic acquisitions. The Company is a biotech/agtech R&D company involved in the commercialization of nutritional and medicinal products derived from proprietary algal strains.

ZIVO Bioscience works to totally harness the beneficial effects of its natural bioactive agents and make them affordable and readily available in a useful and convenient form. The Company has more recently continued to concentrate almost exclusively on dairy cow applications for its proprietary algal biomass, extracts and any high-value bioactive compounds thereof. This is while developing the business case and production scale-up to cultivate and productize the algal biomass.

ZIVO Biosceince’s core IP consists of the algae culture itself, the patented process of producing that culture, and the bioactive compounds or molecules that can be extracted, as well as the application of that culture or extract in supporting health maintenance and longevity.

The Company’s plan is to approach the near-term markets first: animal applications, human food ingredients and human dietary supplements. This is while laying the base for the more complex and longer-term opportunities in the medicinal and pharmaceutical market verticals.

Recently, ZIVO Bioscience announced that Mr. William P. Pfund joined the Company as its new Vice-President of Research & Development. Mr. Pfund will manage overall research goals and compliance initiatives. He will also help transition ZIVO’s ongoing R&D into marketable products and licenses.

Dr. Amy Steffek will continue in her role as Director, Research & Development. She will concentrate mainly on conducting the different tests, studies, and experiments, and manage the data and findings, which populate the ZIVO intellectual property (IP) portfolio. In addition, Dr. Paul Wooley will continue in his role as consulting immunologist.

ZIVO Bioscience, Inc. (ZIVO), closed Tuesday's trading session at $0.12805, up 3.47%, on 121,900 volume with 21 trades. The average volume for the last 3 months is 87,525 and the stock's 52-week low/high is $0.002/$0.189.

chart

MYnd Analytics, Inc. (MYND)

Stock Twits, Zacks, Equity Clock, NASDAQ.com, Capital Cube, BioSpace, MarketWatch, Simply Wall St, 4-Traders, Barchart, OTC Markets, The Street, BusinessInsider.com, Bzweekly.com, GuruFocus, and Marketbeat.com reported on MYnd Analytics, Inc. (MYND), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

MYnd Analytics, Inc. is a predictive medicine company headquartered in Mission Viejo, California. Mynd brings objective physical findings to psychiatric treatment to lessen trial and error treatment in mental health. The Company provides a unique set of reference data and analytic tools for clinicians and researchers in psychiatry. Mynd Analytics lists on the NasdaqCM.

MYnd Analytics has its Psychiatric EEG Evaluation Registry, or PEER Online®. The goal of PEER Online is to provide objective, personalized data to assist physicians in the selection of appropriate medications.

PEER Online is a cloud-based platform. It is a registry and reporting platform. It enables medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG).

Mynd Analytics has its MYnd Analytics Center. This Center provides a convenient, relaxing, and welcoming environment for one to receive their EEG and PEER Report™. The EEG is performed on-site at the MYnd Analytics Center. It usually takes less than one hour. The EEG and PEER Report are available by appointment only.

PEER underwent development by physicians to provide objective information regarding medication response for similar patients. PEER combines a "crowdsourced" secure physician outcome registry with electroencephalogram (EEG), an accepted, well-normed test of brain function. EEG is a completely painless, non-invasive test. It records one’s brain’s electrical activity.

Based on MYnd Analytics original physician-developed database, there are presently more than 39,000 outcomes for over 11,000 unique patients in the PEER registry.

Essentially, physicians built this platform, they contribute new outcomes as they see patients, and they will never be finished building the registry. Physicians who use PEER reduce trial and error prescribing.

Recent highlights for MYnd Analytics include completing the acquisition of revenue-generating Arcadian Telepsychiatry Services. The anticipation is that this acquisition will produce fast growth and benefits from cross-selling going forward.

Recent highlights for the Company also include the first patient enrolled in a 600-patient paid pilot with Horizon Healthcare Services, Inc. This is to improve patient care over trial and error medication management and to lessen total costs of care. Also, MYnd ended the Fiscal Year with a strong balance sheet; more than $5 million of cash.

MYnd Analytics announced last month that it received its first notice of patent allowance in Canada on its neuromodulation platform for predicting patients likely to respond to Transcranial Magnetic Stimulation (TMS). The patent is entitled “Method for Assessing the Susceptibility of a Human Individual Suffering from a Psychiatric or Neurological Disorder to Neuromodulation Treatment.”

It provides patent protection through 2029.  In addition, MYnd has applied for patents in the U.S. It expects these will be awarded later in 2018.

Recently, Advanzeon Solutions, Inc. (CHCR) and MYnd Analytics announced that Advanzeon’s wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. (PVMS), and MYnd’s wholly-owned subsidiary, Arcadian Telepsychiatry Services, entered into an Agreement, expanding PVMS’ and Arcadian’s collaboration.

PVMS, by way of its SMS Sleep Apnea Program, is a national leader in the screening, testing and treating (when indicated) of sleep apnea. Its area of expertise presently centers on the commercial trucking industry and encompasses all 50 States.

MYnd Analytics, Inc. (MYND), closed Tuesday's trading session at $1.64, up 4.46%, on 17,571 volume with 60 trades. The average volume for the last 3 months is 190,181 and the stock's 52-week low/high is $0.62/$4.08.

chart

Trevali Mining Corporation (TREVF)

Streetwise Reports, MarketWatch, OTC Markets, InvestorsHub, Stockhouse, InvestingNews.com, StreetInsider, JuniorMiningNetwork.com, NorthernMiner.com, TipRanks, YCharts, Marketwired, Capital Cube, Mining.com, GuruFocus, Investopedia, Stockwatch, ResourceWorld.com, Stockinvest.us, and Emerging Growth reported on Trevali Mining Corporation (TREVF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Trevali Mining Corporation is a zinc-focused, base metals company headquartered in Vancouver, British Columbia. Its strategy includes attaining mid-tier Mining Company status via a combination of organic growth and unique deals and strategic alliances. The Company previously went by the name Trevali Resources Corp. It changed its name to Trevali Mining Corporation in April of 2011. Incorporated in 1964, Trevali Mining lists on the OTC Markets Group’s OTCQB.

The Company is focusing exploration activities in highly prospective, under-explored terrain in nations and regions that offer security of tenure and support mineral deposit development. Trevali Mining is a pure-play producer with industry-leading leverage to zinc with 80-85 percent of revenue coming from zinc production.

Production has risen annually for five straight years. Resources at all mines remain open for expansion with exploration drill programs continuing. Glencore is a cornerstone strategic shareholder - 25.6 percent.

Trevali Mining has four mines. These are the wholly-owned Santander mine in Peru, the wholly-owned Caribou mine in the Bathurst Mining Camp of northern New Brunswick, Trevali Mining’s 80 percent owned Rosh Pinah mine in Namibia, and its 90 percent owned Perkoa mine in Burkina Faso.

In addition, Trevali Mining owns the Halfmile and Stratmat base metal deposits in the Province of New Brunswick. At present, these are undergoing a Preliminary Economic Assessment (PEA) reviewing their potential development.

Last month, Trevali Mining announced the latest results of its 2017 exploration campaign at the Caribou Zinc Mine in the Bathurst Mining Camp of New Brunswick. Directional exploration drilling defined a significant body of massive sulphide mineralization containing major zinc-rich polymetallic intervals. As presently defined, the zone is centered roughly 350 meters from the currently defined deposit. Moreover, it remains open for expansion.

Also concerning the Bathurst Mining Camp, Trevali Mining acquired five strategic mineral claim blocks from partner Glencore subject to a 2 percent NSR (Net Smelter Return) for any future production for a total of 3,520 ha of area, expanding Trevali's total land holdings to 11,380 ha in the Camp.

Recently, Trevali Mining reported preliminary consolidated Q4 2017 production of 104.8-million payable pounds of zinc, 13.5-million payable pounds of lead and 396,899 payable ounces of silver. Preliminary 2017 annual production was 177.4-million payable pounds of zinc, 45.8-million payable pounds of lead and 1,561,508 payable ounces of silver.

The Company had record overall consolidated Q4-2017 and 2017 annual zinc and lead production. It had its highest annual zinc production, mill throughput and mine output at the Perkoa mine.

Trevali Mining had record quarterly metal production, mine output and mill throughput at the Caribou mine. The continuing transition to owner mining has enabled productivity improvements.

The Rosh Pinah mill re-grind circuit completed in Q4. It is anticipated to increase recoveries and increase concentrate quality. The Company states that the integration of the Perkoa and Rosh Pinah mines, acquired from Glencore on August 31, 2017, continues to progress well.

Trevali Mining Corporation (TREVF), closed Tuesday's trading session at $0.2678, up 5.81%, on 6,450 volume with 3 trades. The average volume for the last 3 months is 90,110 and the stock's 52-week low/high is $0.239/$1.159.

chart

Cannabis Sativa, Inc. (CBDS)

Cannabis Financial Network News, Greenbackers, TheMicrocapNews, TopStockAnalysts, Flagler Financial Group, Promotion Stock Secrets, Jason Bond, Marketbeat.com, TopPennyStockMovers, Stockgoodies, Top Pros’ Top Picks, Insider Financial, Darwin Investing Network, Wall Street Mover, Stock Beast, smartOTC, and Real Pennies reported earlier on Cannabis Sativa, Inc. (CBDS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Cannabis Sativa, Inc. involves in branding and licensing by way of its 'hi' intellectual properties. The Company engages, through its subsidiaries, Wild Earth Naturals and "hi" Brands International, Inc., in the research, development, and licensing of specialized natural products. These include formulas, edibles, topicals, recipes, as well as delivery systems. Cannabis Sativa has been active in pursuing Intellectual Property (IP) and has successfully acquired a growing portfolio of IP. Based in Mesquite, Nevada, Cannabis Sativa’s shares trade on the OTC Markets’ OTCQB.

Cannabis Sativa brands, licenses, innovates, and markets first-rate plant-derived topical creams, transdermals, balms, sublinguals, lubricants, and edibles for medical and recreational marijuana consumers, and legal nutraceuticals and branded merchandise for consumers in general. The Company’s objective is to license the "hi" brand to distributors and producers of quality products and to other ancillary participants in the retail cannabis industry.

Cannabis Sativa has acquired a majority ownership interest in iBudtender, Inc., a Colorado corporation. In addition, it entered into an agreement to acquire a 49 percent ownership interest in a nine-acre property in Los Angeles County, California. The ownership group’s plan is to lease the property to an industrial hemp farm operator. The operator will conduct farming activities under the Industrial Hemp provisions of California's Adult Use Marijuana Act (Prop 64).

Cannabis Sativa has its Wild Earth Naturals offerings. The Company offers the Wild Earth Naturals line of CBD Water and cosmetic products designed to use organic and natural ingredients. These include CBD and hemp seed oil. Cannabis Sativa’s wholly-owned subsidiary, Hi Brands International, entered into an agreement with Centuria Natural Foods, Inc. to market their proprietary CBD Rich Hemp Oil products. Their CBD capsules are marketed under the name, "hi CBD."

Cannabis Sativa has entered into a license agreement for the manufacture, marketing, and sale of its White Rabbit products in California. The Company closed its acquisition of the White Rabbit brand of cannabis sprays and cannabis mints. The acquisition includes the exclusive and proprietary product formulations, product mixes, manufacturing methods, and branding. The White Rabbit product line now consists of fast-acting low dose cannabis oral sprays and low dose cannabis mints. Cannabis Sativa has developed a "hi" branded infused honey product (hi honey) made from rich African honey and infused with CBD or THC.

Cannabis Sativa has acquired a controlling interest in PrestoCorp (a.k.a. PrestoDoctor). This is an online telemedicine platform. It provides access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation utilizing secure video conferencing technology. Appointments via PrestoDoctor's website are usually completed in 10-15 minutes. They can be scheduled and completed in the same day.

PrestoDoctor has greater than 4,000 5-star reviews. It is the first medical marijuana company to be accepted into the American Telemedicine Association. PrestoDoctor is HIPAA and HITECH compliant.

Cannabis Sativa announced in September that it granted an exclusive license to the Sowilde Management Group, Inc. This is to allow Sowilde to produce products under Cannabis Sativa’s "hi" and "White Rabbit" brands. The initial products offered to the market by Sowilde are the White Rabbit line of cannabis sprays and cannabis mints and hi Infused Wild Honey.

Cannabis Sativa, Inc. (CBDS), closed Tuesday's trading session at $2.988, up 0.59%, on 51,351 volume with 176 trades. The average volume for the last 3 months is 89,126 and the stock's 52-week low/high is $1.92/$8.50.

chart

Dais Analytic Corp. (DLYT)

StockEgg, StockRich, Stockpalooza, Money Morning, Penny Stock Rumble, FeedBlitz, M2 Communications, HotOTC, SmallCap Pulse, BullRally, SmallCapVoice, CoolPennyStocks, MadPennyStocks, PennyInvest, PennyStockVille, and Greenbackers reported previously on Dais Analytic Corp. (DLYT), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Dais Analytic Corp sells its industry-changing nanomaterial technology into the worldwide water, air, and energy markets. A commercial nanotechnology materials business, the Company provides nanotechnology-based applications for heating & cooling, water treatment, and energy storage. It is commercializing its inventive Aqualyte™ family of nano-structured materials and processes focusing on disruptive air, energy, and water applications. Dais Analytic is based in Odessa, Florida.

The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™. This is a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product). Additionally, the uses include NanoAir™. This is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle.

Uses also include NanoClear™. This is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water. The NanoClear™ process has consistently shown that Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, attaining almost 'parts per billion' clean product water with little or no fouling of the vital membrane component.

NanoClear™ is a cutting-edge water cleaning architecture enabled by the features in the Company’s nanomaterial - Aqualyte™. The NanoClear™ product line is a vital application in purifying contaminated water having high salt content, low pH, or where the need for Total Dissolved Solid (TDS) in the product water is 10 or less.

Uses also include NanoCAP™. Dais indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive, non-chemical, energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, as well as 'smart grid' configurations.

In June 2017, Dais Analytic announced that it delivered its initial Environmental Navigator™ System in China. The Company also signed up its first new in-country Distributor who has started selling this new advanced product. The Environmental Navigator considerably improves Indoor Air Quality (IAQ) by providing fresh, filtered air with less airborne particles in the indoor space.

The Environmental Navigator utilizes Dais Analytic's award-winning ConsERV™ Energy Recovery Ventilator technology to precondition this fresh air, delivering up to 70 percent energy savings managing ventilation air and in numerous situations the ability to downsize the HVAC plant size by up to a 1/3rd.

Recently, Dais Analytic announced it signed a 7 year, non-exclusive agreement with the Menred Group, Zhejiang province, China. This agreement is to provide its Aqualyte moisture transfer nanomaterial for use in a newer line of Menred energy recovery ventilators (ERV) to sell into the rising Chinese heating, ventilation and air conditioning (HVAC) market.

Dais Analytic Corp. (DLYT), closed Tuesday's trading session at $0.0059, up 18.00%, on 556,500 volume with 18 trades. The average volume for the last 3 months is 218,806 and the stock's 52-week low/high is $0.004/$0.0875.

chart

The QualityStocks Company Corner

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce the appointment of new Director, Mr. Steve Giblin. Mr. Giblin is an accomplished leader in the Global hospitality, technology and real estate industries with a demonstrated track record of value creation.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $3.40, up 4.62%, on 277,159 volume with 205 trades. The stock's 52-week low/high is $0.769/$3.40.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was highlighted today in a publication from Financialnewsmedia.com, examining how cannabis growers are increasing revenues in a number of ways. They seek more acreage. They look for the better growing techniques. They look for better strains.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.62, up 1.25%, on 596,949 volume with 885 trades. The average volume for the last 3 months is 528,050 and the stock's 52-week low/high is $0.85/$2.04.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures (OTC: NUGS) cultivates and partners with brands internationally to develop leaders in the cannabis and CBD marketplace. The company recently added to its staffing capabilities through the acquisition of Worldwide Staffing Group. To view the full article, visit: http://nnw.fm/fnK5G.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.18, up 1.29%, on 25,725 volume with 60 trades. The average volume for the last 3 months is 124,700 and the stock's 52-week low/high is $1.02/$5.94.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom™ (CSE: CHOO) (OTCQB: CHOOF) ("Choom"), an emerging adult and medical use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce it is entering the United States, starting with the state of New Jersey. Also today, the company was highlighted in an article examining how, in both Canada and the U.S., the number of retail stores and dispensaries has been exponentially growing since the end of 2018. The number of restrictive regulations is diminishing while the legalization process has opened more markets. Additionally, the company was highlighted in a report which explains that, running in tandem with the rise of the marijuana stock market has been cannabis companies producing products containing cannabidiol, or CBD.  

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.59145, up 15.74%, on 4,365,209 volume with 1,732 trades. The average volume for the last 3 months is 371,055 and the stock's 52-week low/high is $0.285/$1.129.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

British Columbia-based company Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) engages in the acquisition, exploration and development of resource properties with a focus on lithium extraction. To view the full article, visit: http://nnw.fm/g3JLt.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.2444, up 4.53%, on 120,350 volume with 29 trades. The average volume for the last 3 months is 65,543 and the stock's 52-week low/high is $0.1155/$0.578.

Recent News

chart

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, recently announced that the company's President and CEO Andriyko Herchak is scheduled to deliver a presentation and answer questions during the second annual LD Micro Virtual Conference on Wednesday, March 18 at 2:40 PM ET. To view the presentation, visit: http://nnw.fm/Ts0iI. To view the full press release, visit: http://nnw.fm/yVX77.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.1404, up 12.32%, on 45,040 volume with 14 trades. The average volume for the last 3 months is 44,102 and the stock's 52-week low/high is $0.0577/$0.6259.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

The use of a novel Bria-IMT frozen formulation is one of the exciting new developments that BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) announced recently. Bria-IMT is the company’s lead immunotherapy candidate. It is a novel treatment that works by providing breast cancer antigens that directly stimulate T-cell activity and boost the immune system’s cancer-fighting capabilities in advanced breast cancer patients. Also today, NetworkNewsWire released a report on the company detailing how BCTXF recently secured support for its novel immunotherapy clinical research in the form of an equity investment of C$500,000 by the company’s recently appointed director, Jamieson Bondarenko (http://nnw.fm/dW4iF). To view the full article, visit: http://nnw.fm/G4Etu.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.086, up 1.30%, on 4,200 volume with 4 trades. The average volume for the last 3 months is 19,573 and the stock's 52-week low/high is $0.0495/$0.135.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) has invested in a number of other cannabis companies to grow its portfolio and leverage its position in the market. As the cannabis market grows, companies are seizing the opportunity to make strategic investments in the sector and establish a foothold in the promising space.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0185, up 1.09%, on 2,112,976 volume with 120 trades. The average volume for the last 3 months is 6,073,314 and the stock's 52-week low/high is $0.0106/$0.068.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a publication from Livemoney, explaining how use of cannabidiol (CBD) is on the rise, as nearly 7% of Americans have reported they’re already using CBD products. Now analysts are “conservatively” projecting the cannabis compound’s market to hit US$16 billion by 2025.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.855, off by 4.81%, on 306,253 volume with 534 trades. The average volume for the last 3 months is 211,933 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) recently announced that it has entered into a multi-year extraction services contract with Valens GroWorks Corp. to have the first organically certified hemp-derived CBD products for Canada. Also today, the company was highlighted in an article discussing how cannabis sales have been soaring since legalization in Canada but there's a lot more to come as the industry continues to change. With more retailers opening for business and the edibles market likely coming online this year, there's going to be many more growth opportunities. Furthermore, TGODF was also highlighted in an article looking at how cannabis growers are increasing revenues in a number of ways.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.22, off by 1.59%, on 902,920 volume with 1,322 trades. The average volume for the last 3 months is 1,162,626 and the stock's 52-week low/high is $1.606/$7.894.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Its DehydraTECH drug delivery platform fosters healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules. The company’s process changes the way edible cannabinoids enter the body (http://nnw.fm/8uGHp). Also today, NetworkNewsWire released a report on the company detailing how LXRP plans to conduct additional clinical trials using DehydraTECH(TM) in CBD after recently reporting noteworthy results of cardiovascular performance improvements with TurboCBD. To view the full article, visit: http://nnw.fm/79CSs

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.25, off by 2.15%, on 57,764 volume with 79 trades. The average volume for the last 3 months is 171,353 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

Smart energy technology company Kontrol Energy (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) this morning announced that it has engaged a consultant to assist in its application for eligibility to The Depository Trust Company ("DTC") for trading of the company's shares on the U.S. OTC Market.

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.456, even for the day, on 1,000 volume. The average volume for the last 3 months is 194 and the stock's 52-week low/high is $0.449/$0.70.

Recent News

chart

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN), a Canadian iron ore exploration and development company, is optimistic that construction could begin at its ultra-high-grade Shymanivske Iron Ore Project in Ukraine toward the end of the year. In an upbeat discussion with NNW’s Stuart Smith last month, CEO Matt Simpson, P.Eng., reminded stakeholders of the great strides that Black Iron made in 2018 and the huge leaps that the company is making this year (http://nnw.fm/lFPk2).

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).

Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.

Management

Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.0401, off by 20.75%, on 54,350 volume with 6 trades. The average volume for the last 3 months is 39,125 and the stock's 52-week low/high is $0.0285/$0.0939.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (DVLP) was highlighted today in a report published by Investorideas.com, which takes up the form of a snapshot, looking at the growing number of cannabis companies expanding their CBD capabilities, following the major market trends for 2019.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.0187, off by 4.10%, on 3,167,122 volume with 151 trades. The average volume for the last 3 months is 2,037,905 and the stock's 52-week low/high is $0.0122/$0.14.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.